Advances in the treatment of respiratory disorders.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy / Q000209:etiology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003677:Deficiency Diseases / Q000150:complications; D064420:Drug-Related Side Effects and Adverse Reactions; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D007252:Influenza Vaccines; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008175:Lung Neoplasms / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D011656:Pulmonary Emphysema / Q000150:complications; D012131:Respiratory Insufficiency / Q000188:drug therapy; D012140:Respiratory Tract Diseases / Q000139:chemically induced / Q000628:therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012907:Smoking; D014361:Trypsin Inhibitors / Q000378:metabolism; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D007252:Influenza Vaccines; D014361:Trypsin Inhibitors